POMPANO BEACH, Florida (June 29, 2021)—International Medical Industries, Inc., which focuses on secure drug delivery technologies, has announced its expansion into the home health market through a strategic partnership with Integrated Medical Systems, Inc. (IMS), a national distributor within the alternate site marketplace.
The collaboration introduces IMI products to home infusion healthcare furthering drug integrity and security from pharmacy to patient.
IMI's tamper-evident products are standard of care for outsourced pharmacy compounders. In addition to the widely popular Tamper Evident Caps for syringes and IV Bags, IMI boasts a 50-year history of medical device manufacturing prowess with a variety of disposable medical devices that meet specialized needs. The new partnership with IMS offers a significant opportunity to expand and provide products to the home health market that has been largely underserved with tamper-evident products. These products will enhance IMS's product catalog, which includes a comprehensive line of medical disposable devices from top manufacturers. Their 11 full-service distribution and biomedical service centers supply products for home infusion, respiratory therapies, enteral feeding, United States Pharmacopeia cleanrooms, personal protection and more.
"At IMS we take pride in being able to offer our customers innovative and unique products specialized for pharmaceutical and compounding professionals that deliver high-quality, high-value, drug delivery devices and connectors," said Tim McNamara, vice president of sales and marketing for IMS. "We are very excited about our new partnership with IMI. This means we are now able to provide a superior solution for secure drug delivery for patients."
The partnership aims to increase accessibility and convenience for health care providers, provide new securities for specialty compounds in alternate care, and harmonize tamper evident standards of care across the health care industry.
